| Breakdown | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 294.10M | 401.43M | 413.23M | 569.03M | 594.22M |
| Gross Profit | 143.21M | 250.80M | 269.23M | 357.85M | 355.32M |
| EBITDA | -80.97M | 7.03M | -14.77M | 57.94M | 24.37M |
| Net Income | -100.78M | -23.54M | -50.27M | 2.98M | 106.15M |
Balance Sheet | |||||
| Total Assets | 574.25M | 744.08M | 802.45M | 888.09M | 1.16B |
| Cash, Cash Equivalents and Short-Term Investments | 327.91M | 397.77M | 409.67M | 479.88M | 754.88M |
| Total Debt | 7.75M | 20.46M | 37.30M | 67.51M | 26.91M |
| Total Liabilities | 90.84M | 125.97M | 138.81M | 182.75M | 147.13M |
| Stockholders Equity | 483.41M | 613.78M | 655.52M | 696.01M | 997.68M |
Cash Flow | |||||
| Free Cash Flow | -1.42M | 32.77M | -29.24M | -25.65M | 87.25M |
| Operating Cash Flow | 2.91M | 42.26M | -12.85M | -4.25M | 94.05M |
| Investing Cash Flow | 5.67M | 36.30M | -49.83M | -21.06M | 240.86M |
| Financing Cash Flow | -47.28M | -59.25M | -47.07M | -294.16M | -53.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$510.78M | 1.91 | 28.87% | 5.45% | 31.25% | 147.52% | |
70 Outperform | HK$761.76M | 2.92 | 16.16% | 4.60% | ― | ― | |
62 Neutral | HK$490.98M | 8.99 | -10.55% | 11.54% | -1.38% | -275.02% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | HK$1.57B | -0.82 | -13.27% | ― | -11.17% | -621.38% | |
48 Neutral | HK$215.30M | -1.27 | -18.87% | ― | -30.45% | -97.13% | |
44 Neutral | HK$20.72M | 119.63 | ― | ― | -48.40% | 66.36% |